Indication

Hemangioblastoma

1 clinical trial

1 product

Clinical trial
A Phase 2 Study of SU011248 (Sunitinib Malate) in Von Hippel-Lindau Syndrome
Status: Terminated, Estimated PCD: 2011-05-01
Product
SU011248